Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Sanofi

Drugmakers sued over insulin prices

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

Salon

More states are doing what they can to cap insulin costs

In her early 20s, Karisa Hunt learned the hard lesson of what happens when someone rations life-preserving medication.

Tribune News Service

Eli Lilly, insulin makers sued by California over prices

Eli Lilly & Co., Novo Nordisk AS and Sanofi were sued by California over insulin prices, which the state claims are inflated through unfair and deceptive practices and disproportionately affect low-income households and people of color.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

California latest to sue drug companies over insulin prices

California says it will sue the companies that make and promote much of the nation's insulin

The Independent UK

Pharma giant Sanofi rolls out made-in-France Covid booster jab

French pharmaceutical giant Sanofi on Thursday launched its much-awaited Covid vaccine. The VidPrevtyn Beta booster jab was developed in France and will be available to anyone over 18 in chemists throughout the country.

Radio France Internationale

Medicine shortage hits as France grapples with health 'tripledemic'

France is one of several countries facing shortages of the widely used antibiotic amoxicillin and other medications, with surging illnesses among children increasing demand for the drugs.

Radio France Internationale

GSK shares surge as US judge dismisses Zantac cancer claims

About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

RSV: experts explain why rates of this virus are surging this year

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.

The Conversation

Pharmaceutical companies’ stocks dive after verified imposter Twitter account claims ‘insulin is free’

Insulin producers Eli Lilly, Novo Nordisk and Sanofi all reported losses during Friday’s trading

The Independent UK

Biogen tabs veteran pharma leader Viehbacher as next CEO

Biogen has picked former Sanofi CEO Christopher Viehbacher to become its next leader, as the drug developer continues to recover from its failed launch of the Alzheimer’s treatment Aduhelm

The Independent UK

3 Stocks That Are Great for Passive Income Investors

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

StockNews.com

Dismay as key cholera vaccine is discontinued

Exclusive: halt to production of Shanchol vaccine alarms WHO amid ‘unprecedented’ global outbreaks

The Guardian - UK

Strangers save tot's life with supply of drugs hit by Ukraine war

Kind strangers have been donating dioralyte to help save an epileptic child after 'national shortage'

Wales Online

Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash…

Wall Street Journal

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And Other Top Financial Stories Wednesday, August 17

CNBC BlackRock To Pledge A$1B In Australian Battery Storage Assets – Report

Financial Times

How science is getting closer to a world without animal testing

New technology involving miniature human organs built in a lab is a step towards better treatments and ending a contentious practice

Benzinga

Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke

Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar

WEKU

Drugmakers are slow to prove medicines that got a fast track to market really work

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Get all your
news in one place.

100's of premium titles.
One news app.

Radio France Internationale

Top French companies pay zero tax, despite year of record profits

The weekly magazine L'Obs is pleased to report that the leading French businesses made record profits in 2021, while the rest of us were cowering in fear of the coronavirus. But did they all pay reasonable taxes in France on those record earnings? L'Obs asked them just that.

Benzinga

The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

How Is The Market Feeling About Sanofi?

Sanofi's (NASDAQ:SNY) short percent of float has fallen 22.22% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 0.14% of all regular shares that are available for trading.

Benzinga

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients

Sanofi SA (NASDAQ:SNY) said that uninsured diabetes patients in the U.S. will pay no more than $35 for a 30-day supply of insulin, down from $99. Sanofi said the new price would be effective from July 1. The announcement from Sanofi follows House passage (232-193) of the monthly cap in March, with just 12…

Benzinga

The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Benzinga Before The Bell: Gun Safety Bill. Bill Gates North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24

Reuters

1 … 5 6 7 8

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.